Skip to content Skip to sidebar Skip to footer

Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

600 articles published

Market news

ASX 200 Falls 7.5% in March 2026: Is April a Recovery Opportunity or More Pain Ahead?

ASX 200 Sinks in March: What Comes Next in April? The S&P/ASX 200 closed March at 8,501.80, down approximately 7.5% for the month and its worst monthly performance since June 2022. The index sits roughly 8% below its all-time high of 9,202 set in late February. Three forces drove the selloff: an energy shock from…

ByUjjwal MaheshwariApril 1, 20260Comments

Energy Stocks

Brent Crude Hits US$118 After Iran Strikes Dubai Tanker: Is It Too Late to Buy ASX Energy Stocks?

ASX energy stocks rally: buy now or wait? An Iranian drone struck the Kuwaiti oil tanker Al-Salmi at Dubai Port's anchorage overnight, setting the fully loaded vessel ablaze and sending oil prices even higher. All 24 crew members are safe, and the fire has been brought under control. But the message this attack sends to…

ByUjjwal MaheshwariApril 1, 20260Comments

Healthcare Stocks

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

4 ASX Healthcare Stocks to Buy at Valuation Lows ASX healthcare stocks have had a brutal run. Five years of underperformance, persistent earnings downgrades, and aggressive rate hikes have pushed the sector to levels many investors have not seen in a generation. According to Wilsons Advisory, ASX 100 healthcare stocks now trade at two-decade lows…

ByUjjwal MaheshwariMarch 30, 20260Comments

Travel Stocks

Qantas (ASX:QAN) Falls 33% on Fuel Cost Fears, But Europe Demand Tells a Very Different Story

Is Qantas a buy? Qantas (ASX: QAN) has fallen roughly 33% from its all-time high of A$12.62, set in August 2025, with shares sitting around A$8.45 as of Thursday’s close. While that decline began before the current conflict, the Iran war has accelerated the selloff sharply since late February as jet fuel prices surged from…

ByUjjwal MaheshwariMarch 30, 20260Comments

Healthcare Stocks

Lumos Diagnostics (ASX: LDX) Falls Despite FDA Win- Here’s Why the Dip Could Be a Buying Opportunity

Lumos Diagnostics Falls After FDA Waiver Lumos Diagnostics (ASX: LDX) slipped around 3.8% on Friday despite announcing one of the most important milestones in its history. The US Food and Drug Administration granted a CLIA waiver for its flagship FebriDx test, a development that expands the company's addressable US market by 15 times. The dip…

ByUjjwal MaheshwariMarch 30, 20260Comments

Industrials

Is Duratec (ASX: DUR) a Buy After the PNG Contract Win, or Has the Rally Run Its Course?

Duratec Shares Rise on Newmont PNG Contract Duratec (ASX: DUR) landed a significant A$45 million contract from Lihir Gold, a subsidiary of global mining giant Newmont. It is a meaningful win that confirms the company's growing reach beyond its home market. The market responded positively, with shares rising 3.32% on the day, though the stock…

ByUjjwal MaheshwariMarch 30, 20260Comments

Real Estate

ASX REIT Stocks to Buy, Hold, and Avoid Right Now as Rate Hikes Return

ASX REITs are back under pressure as rate hikes return The Reserve Bank of Australia has now delivered two rate hikes in 2026, pushing the cash rate to 4.10%. The March decision was a razor-thin 5-4 split on the board, meaning May is live but far from a foregone conclusion. For ASX REIT investors, the…

ByUjjwal MaheshwariMarch 28, 20260Comments

Market news

ASX Weekly Wrap March 2026: Gold Crashes, DRO Surges and Five Stories That Shaped the Market

It was one of those weeks where the market gave with one hand and took with the other. The ASX 200 climbed 1.85% on Wednesday to 8,534 points when ceasefire hopes briefly lifted sentiment, then retreated sharply as those hopes collapsed by Thursday. By Friday, US futures were pointing lower, and investors were left asking…

ByUjjwal MaheshwariMarch 28, 20260Comments

Mining Stocks

Syrah Resources (ASX: SYR) Slides Despite US Government Taking 20% Stake- Is This a Buy?

Syrah Resources Falls Despite US Government Backing Syrah Resources (ASX: SYR) is doing something unusual right now: falling on what looks like genuinely good news. The US government's development finance arm has just taken a roughly 20% stake in the company and added fresh capital into its Mozambique graphite mine. That kind of backing would…

ByUjjwal MaheshwariMarch 28, 20260Comments

Energy Stocks Uranium Stocks

Silex Systems (ASX: SLX) Surges 13.5% as Iran Tensions Revive Nuclear Energy: Buy Now or Wait for a Pullback?

Silex gains on nuclear demand, but risks remain Silex Systems (ASX: SLX) surged 13.5% to A$5.55 earlier this week as escalating tensions in the Middle East pushed investors towards nuclear energy and fuel security stocks. The Iran conflict reminded markets just how vulnerable the West remains when it comes to uranium enrichment supply, and Silex…

ByUjjwal MaheshwariMarch 28, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

ASX 200 Falls 7.5% in March 2026: Is April a Recovery Opportunity or More Pain Ahead?

Brent Crude Hits US$118 After Iran Strikes Dubai Tanker: Is It Too Late to Buy ASX Energy Stocks?

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

Qantas (ASX:QAN) Falls 33% on Fuel Cost Fears, But Europe Demand Tells a Very Different Story

Lumos Diagnostics (ASX: LDX) Falls Despite FDA Win- Here’s Why the Dip Could Be a Buying Opportunity

Is Duratec (ASX: DUR) a Buy After the PNG Contract Win, or Has the Rally Run Its Course?

ASX REIT Stocks to Buy, Hold, and Avoid Right Now as Rate Hikes Return

ASX Weekly Wrap March 2026: Gold Crashes, DRO Surges and Five Stories That Shaped the Market

Syrah Resources (ASX: SYR) Slides Despite US Government Taking 20% Stake- Is This a Buy?

Silex Systems (ASX: SLX) Surges 13.5% as Iran Tensions Revive Nuclear Energy: Buy Now or Wait for a Pullback?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here